In the present study, we used IL-17A as target because it is a proinflammatory cytokine that has been implied in many autoimmune diseases such as rheumatoid arthritis (17), psoriasis (18), Crohn's disease (19), multiple sclerosis (20), and lupus erythematosus (21). Here, IL17A is linked to rheumatoid arthritis.